An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
Status: Completed
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
The purpose of this study is to determine whether early use of a bland emollient in newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the development of atopic dermatitis.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 1 month
Healthy Volunteers: f
View:
• at least one parent diagnosed with Atopic Dermatitis
• one parent or sibling with hayfever or asthma
Locations
United States
Oregon
Oregon Health & Science University, Department of Dermatology
Portland
Time Frame
Start Date: 2006-11
Completion Date: 2009-11
Participants
Target number of participants: 22
Treatments
Experimental: Emollient
Skin barrier protection from birth
Authors
Susan Tofte, Alfons Krol, Jon Hanifin
Related Therapeutic Areas
Sponsors
Collaborators: Galderma R&D
Leads: Oregon Health and Science University